Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2026-09-16 16:05:15 ET · period of report 2026-09-15 · accession 0001589776-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-09-16 16:05 | 2026-09-15 | FENC | Brughera Marco Maria | Dir | M - OptEx | $2.11 | +15.5K | 15.5K | New | +$32.8K |
| DT | 2026-09-16 16:05 | 2026-09-15 | FENC | Brughera Marco Maria | Dir | S - Sale+OE | $10.29 | -15.5K | 0 | -100% | -$160.0K |
| DT | 2026-09-16 16:05 | 2026-09-15 | FENC | Brughera Marco Maria | Dir | M - OptEx | $0.00 | -15.5K | 220.0K | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2026-09-15 | M | A | 15,545 | $2.11 | 15,545 | D | — | — | (F1) Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on June 16, 2026. |
| 2 | Common | Common Shares | 2026-09-15 | S | D | 15,545 | $10.29 | 0 | D | — | — | (F2) Shares sold pursuant to a 10b5-1 plan adopted on June 16, 2026. |
| 3 | Derivative | Stock Option | 2026-09-15 | M | D | 15,545 | $0.00 | 220,000 | D | $2.11 · 2016-12-30 to 2026-12-30 | 15,545 Common shares | (F3) Represents options exercised pursuant to a 10b5-1 plan adopted on June 16, 2026. |